Can-Fite BioPharma Ltd. (TLV:CANF)
672.40
-29.00 (-4.13%)
Jan 30, 2026, 1:44 PM IDT
Can-Fite BioPharma Employees
Can-Fite BioPharma had 5 employees as of December 31, 2024. The number of employees decreased by 3 or -37.50% compared to the previous year.
Employees
5
Change (1Y)
-3
Growth (1Y)
-37.50%
Revenue / Employee
377.36K ILS
Profits / Employee
-5.93M ILS
Market Cap
17.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Sep 30, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 0 | - |
| Dec 31, 2020 | 8 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Bonus BioGroup | 37 |
| BioLineRx | 28 |
| Matricelf | 12 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 9 |
| BioLight Life Sciences | 4 |
Can-Fite BioPharma News
- 12 days ago - Can-Fite BioPharma (CANF) Completes Patient Enrollment in Pancreatic Cancer Trial - GuruFocus
- 5 weeks ago - Can-Fite BioPharma (CANF) Announces 1-for-3,000 Reverse Stock Split - GuruFocus
- 5 weeks ago - Can-Fite BioPharma (CANF) Announces Significant Reverse Split - GuruFocus
- 5 weeks ago - Can-Fite BioPharma approves 1-for-3,000 reverse share split; shares down - Seeking Alpha
- 5 weeks ago - Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change - GlobeNewsWire
- 6 weeks ago - CANF: D. Boral Capital Lowers Price Target But Maintains Buy Rating | CANF Stock News - GuruFocus
- 6 weeks ago - CANF: Can-Fite BioPharma Advances Clinical Trials and Strengthens Financial Position - GuruFocus
- 6 weeks ago - Can-Fite Provides Update on Clinical and Financial Status - GlobeNewsWire